Gilead Q3'26 Revenue Estimate Is 7.79 Billion
Gilead Sciences is scheduled to report Q3'26 results on October 22. Revenue is estimated at 7.79 billion USD and EPS at 2.17 USD; the report time is not specified.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Gilead Sciences is scheduled to report Q3'26 results on October 22. Revenue is estimated at 7.79 billion USD and EPS at 2.17 USD; the report time is not specified.